Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative IFN-alpha in HCC with Low miR-26
NCT01681446Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Aug 2012
- Primary completion
- Aug 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human interferon alpha-1b in hepatocellular carcinoma (HCC), sponsored by Fudan University. Status: unknown.
02
Drugs
recombinant human interferon alpha-1b
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01681446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681446.